Insights

Innovative Biotech Focus M:M Bio operates in the biotechnology research sector with a strong emphasis on developing transformative medicines through collaborative and agile operations, presenting opportunities to provide specialized tech solutions or research tools to support their innovative projects.

Growing Revenue Potential With reported revenues ranging from 1 million to 10 million dollars, M:M Bio appears to be a mid-sized player with expansion potential, making it an attractive prospect for scaled services like cloud infrastructure, data management, and biotech-focused software solutions.

Technology Stack Utilization The company's use of major cloud and web services such as AWS and Cloudflare suggests ongoing digital infrastructure needs, indicating opportunities for cybersecurity, cloud automation, or data analytics offerings tailored to biotech research environments.

Collaborative Culture M:M Bio emphasizes a culture of collaboration and entrepreneurship, which may open doors for partnerships or platforms that enhance team productivity, knowledge sharing, and innovation in biotech research.

Market Positioning Operating in a competitive landscape with similar companies of varying sizes, M:M Bio could benefit from tailored marketing and outreach strategies highlighting its unique agile and entrepreneurial approach to attract potential research collaborations or funding opportunities.

Molecule to Medicine Tech Stack

Molecule to Medicine uses 8 technology products and services including html5media, Amazon Web Services, jQuery, and more. Explore Molecule to Medicine's tech stack below.

  • html5media
    Audio, Video, Graphics
  • Amazon Web Services
    Cloud Hosting
  • jQuery
    Javascript Libraries
  • Google Maps
    Maps
  • Webflow
    Page Builders
  • HSTS
    Security
  • HTTP/3
    Web & Portal Technology
  • GoDaddy
    Web Hosting

Molecule to Medicine's Email Address Formats

Molecule to Medicine uses at least 2 format(s):
Molecule to Medicine Email FormatsExamplePercentage
First@molecule2medicine.comJohn@molecule2medicine.com
87%
First.Last@molecule2medicine.comJohn.Doe@molecule2medicine.com
13%

Frequently Asked Questions

Where is Molecule to Medicine's headquarters located?

Minus sign iconPlus sign icon
Molecule to Medicine's main headquarters is located at 99 Park Drive Milton, England ox14 4ry United Kingdom. The company has employees across 4 continents, including EuropeNorth AmericaOceania.

What is Molecule to Medicine's official website and social media links?

Minus sign iconPlus sign icon
Molecule to Medicine's official website is moleculetomedicine.com and has social profiles on LinkedIn.

What is Molecule to Medicine's SIC code NAICS code?

Minus sign iconPlus sign icon
Molecule to Medicine's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Molecule to Medicine have currently?

Minus sign iconPlus sign icon
As of June 2026, Molecule to Medicine has approximately 44 employees across 4 continents, including EuropeNorth AmericaOceania. Key team members include Chief Operating Officer: S. H.Head Of Precision Medicine And Computational Biology: D. M.Head Of Information Technology: A. B.. Explore Molecule to Medicine's employee directory with LeadIQ.

What industry does Molecule to Medicine belong to?

Minus sign iconPlus sign icon
Molecule to Medicine operates in the Biotechnology Research industry.

What technology does Molecule to Medicine use?

Minus sign iconPlus sign icon
Molecule to Medicine's tech stack includes html5mediaAmazon Web ServicesjQueryGoogle MapsWebflowHSTSHTTP/3GoDaddy.

What is Molecule to Medicine's email format?

Minus sign iconPlus sign icon
Molecule to Medicine's email format typically follows the pattern of First@molecule2medicine.com. Find more Molecule to Medicine email formats with LeadIQ.

When was Molecule to Medicine founded?

Minus sign iconPlus sign icon
Molecule to Medicine was founded in 2015.

Molecule to Medicine

Biotechnology ResearchEngland, United Kingdom11-50 Employees

MTM is a global biotech pioneer celebrated for its uniquely collaborative culture.

Run by entrepreneurs for entrepreneurs, we specialise in co-creating and scaling companies within our global ecosystem. We blend experienced drug discovery with agile operations to foster breakthroughs and deliver transformative medicines.
 
For more information, visit the website or email enquiries@m2m.bio.

Section iconCompany Overview

Headquarters
99 Park Drive Milton, England ox14 4ry United Kingdom
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2015
Employees
11-50

Section iconFunding & Financials

  • $1M$10M

    Molecule to Medicine's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1M$10M

    Molecule to Medicine's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.